This compound is an Fmoc-protected amino acid derivative used as a building block in solid-phase peptide synthesis. It features a 2,2-dimethyloxazolidine ring system, which provides structural rigidity during peptide assembly.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 878797-01-4
Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH
Research reagent for peptide synthesis
Fmoc-Leucine-Serine Pseudoproline
solid phase peptide synthesis building block
(4S)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
research compound
4-Oxazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4S)-
Pharmaceutical intermediate for peptide synthesis
4-CHLORO-2,5-DIFLUOROBENZALDEHYDE
pharmaceutical intermediate
(R)-tert-Butyl (piperidin-3-ylmethyl)carbamate
Pharmaceutical intermediate for drug synthesis
(R)-3-N-Cbz-Aminopyrrolidine
Pharmaceutical intermediate
1-(propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
boronic ester synthetic intermediate
(4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
PQJUKTSKOYOXMZ-UIOOFZCWSA-N
CC1(N([C@@H](CO1)C(=O)O)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C